Aleksander Ślusarczyk (Aleksander Slusarczyk)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Topics

Magnetic Resonance

Prostate Cancer

Top Venues

Annals of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Aleksander Ślusarczyk, Rafał Wolański, Jerzy Miłow, Hanna Piekarczyk, Piotr Lipiński, Piotr Zapała, Grzegorz Niemczyk, Paweł Kurzyna, Andrzej Wrobel, Waldemar Różański, Piotr Radziszewski, Łukasz Zapała
Can We Go beyond Pathology? The Prognostic Role of Risk Scoring Tools for Cancer-Specific Survival of Patients with Bladder Cancer Undergoing Radical Cystectomy. Biomedicines 12 (7) (2024)
Aleksander Ślusarczyk, Hamza Ismail, Łukasz Zapała, Tomasz Piecha, Piotr Zapała, Piotr Radziszewski
ASO Visual Abstract: Changes in the Urinary Microbiome following Transurethral Resection of Non-muscle-invasive Bladder Cancer-Insights from a Prospective Observational Study. Annals of surgical oncology 31 (7) (2024)
Aleksander Ślusarczyk, Hamza Ismail, Łukasz Zapała, Tomasz Piecha, Piotr Zapała, Piotr Radziszewski
ASO Visual Abstract: Changes in the Urinary Microbiome following Transurethral Resection of Non-muscle-invasive Bladder Cancer-Insights from a Prospective Observational Study. Annals of surgical oncology 31 (7) (2024)
Aleksander Ślusarczyk
ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study. Annals of surgical oncology 31 (6) (2024)
Aleksander Ślusarczyk, Karolina Garbas, Patryk Pustuła, Łukasz Zapała, Piotr Radziszewski
Assessing the Predictive Accuracy of EORTC, CUETO and EAU Risk Stratification Models for High-Grade Recurrence and Progression after Bacillus Calmette-Guérin Therapy in Non-Muscle-Invasive Bladder Cancer. Cancers 16 (9) (2024)
Aleksander Ślusarczyk
ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study. Annals of surgical oncology (2024)
Aleksander Ślusarczyk, Hamza Ismail, Łukasz Zapała, Tomasz Piecha, Piotr Zapała, Piotr Radziszewski
ASO Visual Abstract: Changes in the Urinary Microbiome following Transurethral Resection of Non-muscle-invasive Bladder Cancer-Insights from a Prospective Observational Study. Annals of surgical oncology (2024)
Aleksander Ślusarczyk, Rafał Wolański, Jerzy Miłow, Hanna Piekarczyk, Piotr Lipiński, Piotr Zapała, Grzegorz Niemczyk, Paweł Kurzyna, Andrzej Wrobel, Waldemar Różański, Piotr Radziszewski, Łukasz Zapała
Can We Go beyond Pathology? The Prognostic Role of Risk Scoring Tools for Cancer-Specific Survival of Patients with Bladder Cancer Undergoing Radical Cystectomy. Biomedicines 12 (7) (2024)
Aleksander Ślusarczyk, Rafał Wolański, Jerzy Miłow, Hanna Piekarczyk, Piotr Lipiński, Piotr Zapała, Grzegorz Niemczyk, Paweł Kurzyna, Andrzej Wrobel, Waldemar Różański, Piotr Radziszewski, Łukasz Zapała
Can We Go beyond Pathology? The Prognostic Role of Risk Scoring Tools for Cancer-Specific Survival of Patients with Bladder Cancer Undergoing Radical Cystectomy. Biomedicines 12 (7) (2024)
Aleksander Ślusarczyk
ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study. Annals of surgical oncology 31 (6) (2024)
Aleksander Ślusarczyk, Karolina Garbas, Patryk Pustuła, Łukasz Zapała, Piotr Radziszewski
Assessing the Predictive Accuracy of EORTC, CUETO and EAU Risk Stratification Models for High-Grade Recurrence and Progression after Bacillus Calmette-Guérin Therapy in Non-Muscle-Invasive Bladder Cancer. Cancers 16 (9) (2024)
Aleksander Ślusarczyk, Hamza Ismail, Łukasz Zapała, Tomasz Piecha, Piotr Zapała, Piotr Radziszewski
ASO Visual Abstract: Changes in the Urinary Microbiome following Transurethral Resection of Non-muscle-invasive Bladder Cancer-Insights from a Prospective Observational Study. Annals of surgical oncology 31 (7) (2024)
Aleksander Ślusarczyk
ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study. Annals of surgical oncology 31 (6) (2024)
Piotr Zapała, Aleksander Ślusarczyk, Paweł Rajwa, Giorgio Gandaglia, Łukasz Zapała, Fabio Zattoni, Tomasz Lorenc, Guillaume Ploussard, Piotr Radziszewski
Magnetic resonance imaging (MRI) for local staging before salvage radical prostatectomy: a meta-analysis. World journal of urology (2023)
Aleksander Ślusarczyk, Piotr Zapała, Zofia Olszewska-Ślusarczyk, Piotr Radziszewski
The prediction of cancer-specific mortality in T1 non-muscle-invasive bladder cancer: comparison of logistic regression and artificial neural network: a SEER population-based study. International urology and nephrology (2023)
Aleksander Ślusarczyk, Piotr Zapała, Tomasz Piecha, Łukasz Zapała, Tomasz Borkowski, Piotr Radziszewski
Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy. Annals of surgical oncology (2023)
Aleksander Ślusarczyk
ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer. Annals of surgical oncology (2023)
Aleksander Ślusarczyk, Piotr Zapała, Łukasz Zapała, Tomasz Borkowski, Piotr Radziszewski
Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis. Annals of surgical oncology (2023)
Aleksander Ślusarczyk, Piotr Zapała
Reply to Letter to Editor: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer. Annals of surgical oncology (2023)
Aleksander Ślusarczyk, Michael Baboudjian, Piotr Zapała, Shahrokh F Shariat, Marcin Miszczyk, Marcin Chlosta, Paul Krumpoeck, Marco Moschini, Giorgio Gandaglia, Guillaume Ploussard, Juan G Rivas, Marcin Życzkowski, Pierre I Karakiewicz, Piotr Radziszewski, Michael S Leapman, Shahrokh F Shariat, Paweł Rajwa
Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations. The Prostate (2023)
Aleksander Ślusarczyk, Piotr Zapała, Łukasz Zapała, Tomasz Borkowski, Piotr Radziszewski
ASO Visual Abstract: Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer-A Population-Based Analysis. Annals of surgical oncology (2023)
Łukasz Zapała, Aleksander Ślusarczyk, Rafał Wolański, Paweł Kurzyna, Karolina Garbas, Piotr Zapała, Piotr Radziszewski
The Four-Feature Prognostic Models for Cancer-Specific and Overall Survival after Surgery for Localized Clear Cell Renal Cancer: Is There a Place for Inflammatory Markers? Biomedicines 10 (5) (2022)
Aleksandra Kusowska, Matylda Kubacz, Marta Krawczyk, Aleksander Ślusarczyk, Magdalena Winiarska, Malgorzata Bobrowicz
Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma. International journal of molecular sciences 23 (3) (2022)
Piotr Zapała, Karolina Garbas, Zbigniew Lewandowski, Łukasz Zapała, Aleksander Ślusarczyk, Cezary Ślusarczyk, Łukasz Mielczarek, Piotr Radziszewski
The Clinical Utility of Systemic Immune-Inflammation Index Supporting Charlson Comorbidity Index and CAPRA-S Score in Determining Survival after Radical Prostatectomy-A Single Centre Study. Cancers 14 (17) (2022)
Marta Klopotowska, Malgorzata Bajor, Agnieszka Graczyk-Jarzynka, Agnieszka Kraft, Zofia Pilch, Andriy Zhylko, Malgorzata Firczuk, Iwona Baranowska, Michal Lazniewski, Dariusz Plewczyński, Agnieszka Goral, Karolina Soroczynska, Joanna Domagała, Katsiaryna Marhelava, Aleksander Ślusarczyk, Kuba Retecki, Kavita Ramji, Marta Krawczyk, Madison N Temples, Blanka Sharma, Mieszko Lachota, Herman Netskar, Karl-Johan Malmberg, Radoslaw Zagozdzon, Magdalena Winiarska
PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress. Cancer immunology research (2021)
Nina Miazek-Zapala, Aleksander Ślusarczyk, Aleksandra Kusowska, Piotr Zapala, Matylda Kubacz, Magdalena Winiarska, Malgorzata Bobrowicz
The "Magic Bullet" Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era. Cells 10 (6) (2021)